Ai-Hong Ma

Title(s)Scientist, Biochemistry and Molecular Medicine
SchoolSchool of Veterinary Medicine
AddressOak Park Res Bldg Rm2120/UCDH
CA 95817
Phone916-703-5081
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer. Sci Rep. 2023 06 14; 13(1):9617. Steele TM, Tsamouri MM, Siddiqui S, Lucchesi CA, Vasilatis D, Mooso BA, Durbin-Johnson BP, Ma AH, Hejazi N, Parikh M, Mudryj M, Pan CX, Ghosh PM. PMID: 37316561; PMCID: PMC10267166.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    2. Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer. Clin Cancer Res. 2022 11 01; 28(21):4820-4831. Zhu Z, Ma AH, Zhang H, Lin TY, Xue X, Farrukh H, Zhu S, Shi W, Yuan R, Cao Z, Chittepu VCSR, Prabhala R, Li Y, Lam KS, Pan CX. PMID: 35921526; PMCID: PMC9633390.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    3. ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors. JCI Insight. 2022 08 22; 7(16). Rehman H, Chandrashekar DS, Balabhadrapatruni C, Nepal S, Balasubramanya SAH, Shelton AK, Skinner KR, Ma AH, Rao T, Agarwal S, Eich ML, Robinson AD, Naik G, Manne U, Netto GJ, Miller CR, Pan CX, Sonpavde G, Varambally S, Ferguson JE. PMID: 35852858; PMCID: PMC9462490.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    4. Programmable Bispecific Nano-immunoengager That Captures T Cells and Reprograms Tumor Microenvironment. Nano Lett. 2022 09 14; 22(17):6866-6876. Zhang L, Bo R, Wu Y, Li L, Zhu Z, Ma AH, Xiao W, Huang Y, Rojalin T, Yin X, Mao C, Wang F, Wang Y, Zhang H, Low KE, Lee K, Ajena Y, Jing D, Zhang D, Baehr CM, Liu R, Wang L, Li Y, Lam KS. PMID: 35926215; PMCID: PMC9479133.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    5. Preclinical Models for Bladder Cancer Research. Hematol Oncol Clin North Am. 2021 06; 35(3):613-632. Zhu S, Zhu Z, Ma AH, Sonpavde GP, Cheng F, Pan CX. PMID: 33958154; PMCID: PMC8174399.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    6. Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis. Cancer Lett. 2021 04 28; 504:49-57. Katleba K, Lombard AP, Tsamouri MM, Baek HB, Nishida KS, Libertini SJ, Platero AJ, Ma AH, Pan CX, Ghosh PM, Mudryj M. PMID: 33549708; PMCID: PMC7943249.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    7. Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer. Cancer Immunol Immunother. 2020 Nov; 69(11):2305-2317. Long Q, Ma AH, Zhang H, Cao Z, Xia R, Lin TY, Sonpavde GP, de Vere White R, Guo J, Pan CX. PMID: 32506263; PMCID: PMC7572640.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    8. A Simple Three-Dimensional In Vitro Culture Mimicking the In Vivo-Like Cell Behavior of Bladder Patient-Derived Xenograft Models. Cancers (Basel). 2020 May 21; 12(5). Amaral R, Zimmermann M, Ma AH, Zhang H, Swiech K, Pan CX. PMID: 32455634; PMCID: PMC7281103.
      View in: PubMed   Mentions: 9  
    9. Fidelity of a PDX-CR model for bladder cancer. Biochem Biophys Res Commun. 2019 09 10; 517(1):49-56. Mondal AM, Ma AH, Li G, Krawczyk E, Yuan R, Lu J, Schlegel R, Stamatakis L, Kowalczyk KJ, Philips GK, Pan CX, Liu X. PMID: 31303270; PMCID: PMC6777560.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    10. Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia. Nanomedicine. 2019 08; 20:102004. Lin TY, Zhu Y, Li Y, Zhang H, Ma AH, Long Q, Keck J, Lam KS, Pan CX, Jonas BA. PMID: 31055076; PMCID: PMC8237247.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    11. Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model. Nanomedicine. 2018 04; 14(3):789-799. Long Q, Lin TY, Huang Y, Li X, Ma AH, Zhang H, Carney R, Airhart S, Lam KS, deVere White RW, Pan CX, Li Y. PMID: 29317342; PMCID: PMC5898975.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    12. Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy. FASEB J. 2018 03; 32(3):1537-1549. Wang M, Yao LC, Cheng M, Cai D, Martinek J, Pan CX, Shi W, Ma AH, De Vere White RW, Airhart S, Liu ET, Banchereau J, Brehm MA, Greiner DL, Shultz LD, Palucka K, Keck JG. PMID: 29146734; PMCID: PMC5892726.
      View in: PubMed   Mentions: 167     Fields:    Translation:HumansAnimalsCells
    13. COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther. 2018 02; 17(2):474-483. Wang F, Zhang H, Ma AH, Yu W, Zimmermann M, Yang J, Hwang SH, Zhu D, Lin TY, Malfatti M, Turteltaub KW, Henderson PT, Airhart S, Hammock BD, Yuan J, de Vere White RW, Pan CX. PMID: 29284644; PMCID: PMC5824635.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    14. Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells. Sci Rep. 2017 09 25; 7(1):12277. Gheibi P, Zeng S, Son KJ, Vu T, Ma AH, Dall'Era MA, Yap SA, de Vere White RW, Pan CX, Revzin A. PMID: 28947782; PMCID: PMC5612935.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    15. The Phosphatidylinositol 3-Kinase Pathway as a Potential Therapeutic Target in Bladder Cancer. Clin Cancer Res. 2017 Nov 01; 23(21):6580-6591. Zeng SX, Zhu Y, Ma AH, Yu W, Zhang H, Lin TY, Shi W, Tepper CG, Henderson PT, Airhart S, Guo JM, Xu CL, deVere White RW, Pan CX. PMID: 28808038; PMCID: PMC5668181.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    16. Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors. EJNMMI Res. 2016 Dec; 6(1):18. Xiao W, Li T, Bononi FC, Lac D, Kekessie IA, Liu Y, Sanchez E, Mazloom A, Ma AH, Lin J, Tran J, Yang K, Lam KS, Liu R. PMID: 26922417; PMCID: PMC4769701.
      View in: PubMed   Mentions: 15  
    17. miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src. Cancer Res. 2015 Dec 15; 75(24):5309-17. Shi XB, Ma AH, Xue L, Li M, Nguyen HG, Yang JC, Tepper CG, Gandour-Edwards R, Evans CP, Kung HJ, deVere White RW. PMID: 26573802; PMCID: PMC4681619.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    18. CTA095, a novel Etk and Src dual inhibitor, induces apoptosis in prostate cancer cells and overcomes resistance to Src inhibitors. PLoS One. 2013; 8(8):e70910. Guo W, Liu R, Bhardwaj G, Ma AH, Changou C, Yang JC, Li Y, Feng C, Luo Y, Mazloom A, Sanchez E, Wang Y, Huang W, Patterson R, Evans CP, Lam KS, Kung HJ. PMID: 23967135; PMCID: PMC3744530.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    19. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer. PLoS One. 2013; 8(4):e61064. Amir S, Ma AH, Shi XB, Xue L, Kung HJ, Devere White RW. PMID: 23585871; PMCID: PMC3621663.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    20. Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs. Mol Pharmacol. 2012 Nov; 82(5):938-47. Guo W, Liu R, Ono Y, Ma AH, Martinez A, Sanchez E, Wang Y, Huang W, Mazloom A, Li J, Ning J, Maverakis E, Lam KS, Kung HJ. PMID: 22899868; PMCID: PMC3477223.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    21. miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate. 2011 Apr; 71(5):538-49. Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ, White RW. PMID: 20886540; PMCID: PMC3017658.
      View in: PubMed   Mentions: 96     Fields:    Translation:AnimalsCells
    22. Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors. Genes Cancer. 2010 Jan; 1(1):40-9. Wu Z, Chang PC, Yang JC, Chu CY, Wang LY, Chen NT, Ma AH, Desai SJ, Lo SH, Evans CP, Lam KS, Kung HJ. PMID: 20811583; PMCID: PMC2930266.
      View in: PubMed   Mentions: 89  
    23. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc Natl Acad Sci U S A. 2007 Dec 11; 104(50):19983-8. Shi XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, Tepper CG, Evans CP, Kung HJ, deVere White RW. PMID: 18056640; PMCID: PMC2148409.
      View in: PubMed   Mentions: 227     Fields:    Translation:HumansCells
    24. Inappropriate activation of the androgen receptor by nonsteroids: involvement of the Src kinase pathway and its therapeutic implications. Cancer Res. 2006 Nov 01; 66(21):10449-59. Desai SJ, Ma AH, Tepper CG, Chen HW, Kung HJ. PMID: 17079466.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    25. Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells. Cancer Res. 2006 Sep 01; 66(17):8439-47. Ma AH, Xia L, Desai SJ, Boucher DL, Guan Y, Shih HM, Shi XB, deVere White RW, Chen HW, Tepper CG, Kung HJ. PMID: 16951154.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    26. Negative modulation of androgen receptor transcriptional activity by Daxx. Mol Cell Biol. 2004 Dec; 24(24):10529-41. Lin DY, Fang HI, Ma AH, Huang YS, Pu YS, Jenster G, Kung HJ, Shih HM. PMID: 15572661; PMCID: PMC533990.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    27. Molecular alterations associated with LNCaP cell progression to androgen independence. Prostate. 2004 Aug 01; 60(3):257-71. Shi XB, Ma AH, Tepper CG, Xia L, Gregg JP, Gandour-Edwards R, Mack PC, Kung HJ, deVere White RW. PMID: 15176055.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    28. Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc Natl Acad Sci U S A. 2003 Mar 04; 100(5):2226-30. Louie MC, Yang HQ, Ma AH, Xu W, Zou JX, Kung HJ, Chen HW. PMID: 12589022; PMCID: PMC151322.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    29. Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line. Cancer Res. 2002 Nov 15; 62(22):6606-14. Tepper CG, Boucher DL, Ryan PE, Ma AH, Xia L, Lee LF, Pretlow TG, Kung HJ. PMID: 12438256.
      View in: PubMed   Mentions: 104     Fields:    Translation:HumansAnimalsCells
    30. Identification of human male germ cell-associated kinase, a kinase transcriptionally activated by androgen in prostate cancer cells. J Biol Chem. 2002 Sep 20; 277(38):35422-33. Xia L, Robinson D, Ma AH, Chen HC, Wu F, Qiu Y, Kung HJ. PMID: 12084720.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    31. Functional analysis of 44 mutant androgen receptors from human prostate cancer. Cancer Res. 2002 Mar 01; 62(5):1496-502. Shi XB, Ma AH, Xia L, Kung HJ, de Vere White RW. PMID: 11888926.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    Ai-Hong's Networks
    Concepts (202)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (23)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-4-g3cb31450 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California